Dr. Marco Colonna, MD, the Robert Rock Belliveau, MD, Professor of Pathology at Washington University St. Louis School of Medicine and his team found in a study of mice that gut bacteria can enhance cancer immunotherapy, according to a May 17 2024 Medical Express report.
About “one in five cancer patients benefit from immunotherapy—a treatment that harnesses the immune system to fight cancer, adds the study.”
They found an expansion of the Ruminococcus gnavus gut bacteria species plays a key role in mobilizing the body’s immune system to fight cancer”, Colonna. Clinical trials also found fecal transplants containing R. Gnavus from individuals have helped unresponsive patients. What’s next some say is a probiotic supplement that supports cancer immunotherapy.